1378484-08-2Relevant articles and documents
Long-acting peptidomimetics based DPP-IV inhibitors
Jadav, Pradip,Bahekar, Rajesh,Shah, Shailesh R.,Patel, Dipam,Joharapurkar, Amit,Kshirsagar, Samadhan,Jain, Mukul,Shaikh, Mubeen,Sairam, Kalapatapu V.V.M.
supporting information; experimental part, p. 3516 - 3521 (2012/07/03)
Pyrrolidine based peptidomimetics are reported as potent and selective DPP-IV inhibitors for the treatment of T2DM. Compounds 16c and 16d showed excellent in vitro potency and selectivity towards DPP-IV and the lead compound 16c showed sustained antihyper